Global Orlistat

Orlistat Comprehensive Study by Type (120mg, 60mg), Application (Weight-reducing Aid, Other), Distribution Channel (Retailer, Online, Others), Prescription Mode (Prescription Drugs, OTC drugs) Players and Region - Global Market Outlook to 2026

Orlistat Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Orlistat is defined as the drug which is designed to treat obesity. It is mainly used to aid in weight loss. It is mainly used for adults patients who suffering from overweight or obese. According to an article published by the WHO (World Health Organization), in 2016, near 1.9 billion adults who were 18 years and above were overweight. Of these, over 650 million were obese globally. Hence, the increasing number of overweight patient and raising awareness related to health problem are some of the major factors which affect the growth of the market in the future.This growth is primarily driven by Increasing Aging Population and Chronic Nature of Disease, Increasing Prevalence of Obesity and Adoption of Sedentary Lifestyle and Rising Consumption of Fast Foods Coupled with the Lack of Exercise.

Globally, a noticeable market trend is evident Type 2 diabetes, as well as Dual therapy for obesity, is one of the latest trends in the market. For instance, Companies such as AstraZeneca, J&J, and Sanofi, are also adopting the low-risk strategy of using diabetes drugs in order to treat the obesity-related problem. The Pharmaceuticals sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as F. Hoffmann-La Roche AG (Switzerland), GlaxoSmithKline plc (United Kingdom), Teva Pharmaceutical Industries Ltd. (Israel), Sandoz International GmbH (Germany), STADA-VN J.V.Co., Ltd (Vietnam), Hexal AG (Germany), National Company for Pharmaceutical Industry (Oman), Lunan Pharmaceutical Group Co., Ltd. (China), ZEIN pharmaceutical (China) and Zhejiang Hisun Pharmaceutical Co., Ltd. (China) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

In May 2018, the Food Safety and Standards Authority of India has launched SNF (safe and nutritious food) Workplace initiative in order to stem obesity, non-communicable diseases. Hence, it will affect the growth of the market in the future.

Market Drivers
  • Increasing Aging Population and Chronic Nature of Disease
  • Increasing Prevalence of Obesity and Adoption of Sedentary Lifestyle
  • Rising Consumption of Fast Foods Coupled with the Lack of Exercise

Market Trend
  • Type 2 diabetes, as well as Dual therapy for obesity, is one of the latest trends in the market. For instance, Companies such as AstraZeneca, J&J, and Sanofi, are also adopting the low-risk strategy of using diabetes drugs in order to treat the obesity-related problem

Restraints
  • Problem related to Side Effects of the Drugs and Limited Availability of Combination Therapy

Opportunities
Introduction of Novel Anti-Obesity Drugs as well as Untapped Opportunities in Emerging Nations such as China, India, Philippines, and others
Challenges
The issue regarding Some High Prices of Orlistat Drugs is affectation a Challenge for the Market in Future

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Orlistat Study Sheds Light on
— The Orlistat Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Orlistat industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Orlistat industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • 120mg
  • 60mg
By Application
  • Weight-reducing Aid
  • Other
By Distribution Channel
  • Retailer
  • Online
  • Others

By Prescription Mode
  • Prescription Drugs
  • OTC drugs

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Aging Population and Chronic Nature of Disease
      • 3.2.2. Increasing Prevalence of Obesity and Adoption of Sedentary Lifestyle
      • 3.2.3. Rising Consumption of Fast Foods Coupled with the Lack of Exercise
    • 3.3. Market Challenges
      • 3.3.1. The issue regarding Some High Prices of Orlistat Drugs is affectation a Challenge for the Market in Future
    • 3.4. Market Trends
      • 3.4.1. Type 2 diabetes, as well as Dual therapy for obesity, is one of the latest trends in the market. For instance, Companies such as AstraZeneca, J&J, and Sanofi, are also adopting the low-risk strategy of using diabetes drugs in order to treat the obesity-related problem
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Orlistat, by Type, Application, Distribution Channel, Prescription Mode and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Orlistat (Value)
      • 5.2.1. Global Orlistat by: Type (Value)
        • 5.2.1.1. 120mg
        • 5.2.1.2. 60mg
      • 5.2.2. Global Orlistat by: Application (Value)
        • 5.2.2.1. Weight-reducing Aid
        • 5.2.2.2. Other
      • 5.2.3. Global Orlistat by: Distribution Channel (Value)
        • 5.2.3.1. Retailer
        • 5.2.3.2. Online
        • 5.2.3.3. Others
      • 5.2.4. Global Orlistat by: Prescription Mode (Value)
        • 5.2.4.1. Prescription Drugs
        • 5.2.4.2. OTC drugs
      • 5.2.5. Global Orlistat Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Orlistat (Volume)
      • 5.3.1. Global Orlistat by: Type (Volume)
        • 5.3.1.1. 120mg
        • 5.3.1.2. 60mg
      • 5.3.2. Global Orlistat by: Application (Volume)
        • 5.3.2.1. Weight-reducing Aid
        • 5.3.2.2. Other
      • 5.3.3. Global Orlistat by: Distribution Channel (Volume)
        • 5.3.3.1. Retailer
        • 5.3.3.2. Online
        • 5.3.3.3. Others
      • 5.3.4. Global Orlistat by: Prescription Mode (Volume)
        • 5.3.4.1. Prescription Drugs
        • 5.3.4.2. OTC drugs
      • 5.3.5. Global Orlistat Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Orlistat (Price)
      • 5.4.1. Global Orlistat by: Type (Price)
  • 6. Orlistat: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. F. Hoffmann-La Roche AG (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GlaxoSmithKline plc (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sandoz International GmbH (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. STADA-VN J.V.Co., Ltd (Vietnam)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Hexal AG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. National Company for Pharmaceutical Industry (Oman)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Lunan Pharmaceutical Group Co., Ltd. (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. ZEIN pharmaceutical (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Zhejiang Hisun Pharmaceutical Co., Ltd. (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Orlistat Sale, by Type, Application, Distribution Channel, Prescription Mode and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Orlistat (Value)
      • 7.2.1. Global Orlistat by: Type (Value)
        • 7.2.1.1. 120mg
        • 7.2.1.2. 60mg
      • 7.2.2. Global Orlistat by: Application (Value)
        • 7.2.2.1. Weight-reducing Aid
        • 7.2.2.2. Other
      • 7.2.3. Global Orlistat by: Distribution Channel (Value)
        • 7.2.3.1. Retailer
        • 7.2.3.2. Online
        • 7.2.3.3. Others
      • 7.2.4. Global Orlistat by: Prescription Mode (Value)
        • 7.2.4.1. Prescription Drugs
        • 7.2.4.2. OTC drugs
      • 7.2.5. Global Orlistat Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Orlistat (Volume)
      • 7.3.1. Global Orlistat by: Type (Volume)
        • 7.3.1.1. 120mg
        • 7.3.1.2. 60mg
      • 7.3.2. Global Orlistat by: Application (Volume)
        • 7.3.2.1. Weight-reducing Aid
        • 7.3.2.2. Other
      • 7.3.3. Global Orlistat by: Distribution Channel (Volume)
        • 7.3.3.1. Retailer
        • 7.3.3.2. Online
        • 7.3.3.3. Others
      • 7.3.4. Global Orlistat by: Prescription Mode (Volume)
        • 7.3.4.1. Prescription Drugs
        • 7.3.4.2. OTC drugs
      • 7.3.5. Global Orlistat Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Orlistat (Price)
      • 7.4.1. Global Orlistat by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Orlistat: by Type(USD Million)
  • Table 2. Orlistat 120mg , by Region USD Million (2015-2020)
  • Table 3. Orlistat 60mg , by Region USD Million (2015-2020)
  • Table 4. Orlistat: by Application(USD Million)
  • Table 5. Orlistat Weight-reducing Aid , by Region USD Million (2015-2020)
  • Table 6. Orlistat Other , by Region USD Million (2015-2020)
  • Table 7. Orlistat: by Distribution Channel(USD Million)
  • Table 8. Orlistat Retailer , by Region USD Million (2015-2020)
  • Table 9. Orlistat Online , by Region USD Million (2015-2020)
  • Table 10. Orlistat Others , by Region USD Million (2015-2020)
  • Table 11. Orlistat: by Prescription Mode(USD Million)
  • Table 12. Orlistat Prescription Drugs , by Region USD Million (2015-2020)
  • Table 13. Orlistat OTC drugs , by Region USD Million (2015-2020)
  • Table 14. South America Orlistat, by Country USD Million (2015-2020)
  • Table 15. South America Orlistat, by Type USD Million (2015-2020)
  • Table 16. South America Orlistat, by Application USD Million (2015-2020)
  • Table 17. South America Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 18. South America Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 19. Brazil Orlistat, by Type USD Million (2015-2020)
  • Table 20. Brazil Orlistat, by Application USD Million (2015-2020)
  • Table 21. Brazil Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 22. Brazil Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 23. Argentina Orlistat, by Type USD Million (2015-2020)
  • Table 24. Argentina Orlistat, by Application USD Million (2015-2020)
  • Table 25. Argentina Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 26. Argentina Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 27. Rest of South America Orlistat, by Type USD Million (2015-2020)
  • Table 28. Rest of South America Orlistat, by Application USD Million (2015-2020)
  • Table 29. Rest of South America Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 30. Rest of South America Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 31. Asia Pacific Orlistat, by Country USD Million (2015-2020)
  • Table 32. Asia Pacific Orlistat, by Type USD Million (2015-2020)
  • Table 33. Asia Pacific Orlistat, by Application USD Million (2015-2020)
  • Table 34. Asia Pacific Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 35. Asia Pacific Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 36. China Orlistat, by Type USD Million (2015-2020)
  • Table 37. China Orlistat, by Application USD Million (2015-2020)
  • Table 38. China Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 39. China Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 40. Japan Orlistat, by Type USD Million (2015-2020)
  • Table 41. Japan Orlistat, by Application USD Million (2015-2020)
  • Table 42. Japan Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 43. Japan Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 44. India Orlistat, by Type USD Million (2015-2020)
  • Table 45. India Orlistat, by Application USD Million (2015-2020)
  • Table 46. India Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 47. India Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 48. South Korea Orlistat, by Type USD Million (2015-2020)
  • Table 49. South Korea Orlistat, by Application USD Million (2015-2020)
  • Table 50. South Korea Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 51. South Korea Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 52. Taiwan Orlistat, by Type USD Million (2015-2020)
  • Table 53. Taiwan Orlistat, by Application USD Million (2015-2020)
  • Table 54. Taiwan Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 55. Taiwan Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 56. Australia Orlistat, by Type USD Million (2015-2020)
  • Table 57. Australia Orlistat, by Application USD Million (2015-2020)
  • Table 58. Australia Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 59. Australia Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 60. Rest of Asia-Pacific Orlistat, by Type USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific Orlistat, by Application USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 64. Europe Orlistat, by Country USD Million (2015-2020)
  • Table 65. Europe Orlistat, by Type USD Million (2015-2020)
  • Table 66. Europe Orlistat, by Application USD Million (2015-2020)
  • Table 67. Europe Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 68. Europe Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 69. Germany Orlistat, by Type USD Million (2015-2020)
  • Table 70. Germany Orlistat, by Application USD Million (2015-2020)
  • Table 71. Germany Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 72. Germany Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 73. France Orlistat, by Type USD Million (2015-2020)
  • Table 74. France Orlistat, by Application USD Million (2015-2020)
  • Table 75. France Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 76. France Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 77. Italy Orlistat, by Type USD Million (2015-2020)
  • Table 78. Italy Orlistat, by Application USD Million (2015-2020)
  • Table 79. Italy Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 80. Italy Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 81. United Kingdom Orlistat, by Type USD Million (2015-2020)
  • Table 82. United Kingdom Orlistat, by Application USD Million (2015-2020)
  • Table 83. United Kingdom Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 84. United Kingdom Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 85. Netherlands Orlistat, by Type USD Million (2015-2020)
  • Table 86. Netherlands Orlistat, by Application USD Million (2015-2020)
  • Table 87. Netherlands Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 88. Netherlands Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 89. Rest of Europe Orlistat, by Type USD Million (2015-2020)
  • Table 90. Rest of Europe Orlistat, by Application USD Million (2015-2020)
  • Table 91. Rest of Europe Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 92. Rest of Europe Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 93. MEA Orlistat, by Country USD Million (2015-2020)
  • Table 94. MEA Orlistat, by Type USD Million (2015-2020)
  • Table 95. MEA Orlistat, by Application USD Million (2015-2020)
  • Table 96. MEA Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 97. MEA Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 98. Middle East Orlistat, by Type USD Million (2015-2020)
  • Table 99. Middle East Orlistat, by Application USD Million (2015-2020)
  • Table 100. Middle East Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 101. Middle East Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 102. Africa Orlistat, by Type USD Million (2015-2020)
  • Table 103. Africa Orlistat, by Application USD Million (2015-2020)
  • Table 104. Africa Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 105. Africa Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 106. North America Orlistat, by Country USD Million (2015-2020)
  • Table 107. North America Orlistat, by Type USD Million (2015-2020)
  • Table 108. North America Orlistat, by Application USD Million (2015-2020)
  • Table 109. North America Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 110. North America Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 111. United States Orlistat, by Type USD Million (2015-2020)
  • Table 112. United States Orlistat, by Application USD Million (2015-2020)
  • Table 113. United States Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 114. United States Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 115. Canada Orlistat, by Type USD Million (2015-2020)
  • Table 116. Canada Orlistat, by Application USD Million (2015-2020)
  • Table 117. Canada Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 118. Canada Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 119. Mexico Orlistat, by Type USD Million (2015-2020)
  • Table 120. Mexico Orlistat, by Application USD Million (2015-2020)
  • Table 121. Mexico Orlistat, by Distribution Channel USD Million (2015-2020)
  • Table 122. Mexico Orlistat, by Prescription Mode USD Million (2015-2020)
  • Table 123. Orlistat Sales: by Type(k Tons)
  • Table 124. Orlistat Sales 120mg , by Region k Tons (2015-2020)
  • Table 125. Orlistat Sales 60mg , by Region k Tons (2015-2020)
  • Table 126. Orlistat Sales: by Application(k Tons)
  • Table 127. Orlistat Sales Weight-reducing Aid , by Region k Tons (2015-2020)
  • Table 128. Orlistat Sales Other , by Region k Tons (2015-2020)
  • Table 129. Orlistat Sales: by Distribution Channel(k Tons)
  • Table 130. Orlistat Sales Retailer , by Region k Tons (2015-2020)
  • Table 131. Orlistat Sales Online , by Region k Tons (2015-2020)
  • Table 132. Orlistat Sales Others , by Region k Tons (2015-2020)
  • Table 133. Orlistat Sales: by Prescription Mode(k Tons)
  • Table 134. Orlistat Sales Prescription Drugs , by Region k Tons (2015-2020)
  • Table 135. Orlistat Sales OTC drugs , by Region k Tons (2015-2020)
  • Table 136. South America Orlistat Sales, by Country k Tons (2015-2020)
  • Table 137. South America Orlistat Sales, by Type k Tons (2015-2020)
  • Table 138. South America Orlistat Sales, by Application k Tons (2015-2020)
  • Table 139. South America Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 140. South America Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 141. Brazil Orlistat Sales, by Type k Tons (2015-2020)
  • Table 142. Brazil Orlistat Sales, by Application k Tons (2015-2020)
  • Table 143. Brazil Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 144. Brazil Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 145. Argentina Orlistat Sales, by Type k Tons (2015-2020)
  • Table 146. Argentina Orlistat Sales, by Application k Tons (2015-2020)
  • Table 147. Argentina Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 148. Argentina Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 149. Rest of South America Orlistat Sales, by Type k Tons (2015-2020)
  • Table 150. Rest of South America Orlistat Sales, by Application k Tons (2015-2020)
  • Table 151. Rest of South America Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 152. Rest of South America Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 153. Asia Pacific Orlistat Sales, by Country k Tons (2015-2020)
  • Table 154. Asia Pacific Orlistat Sales, by Type k Tons (2015-2020)
  • Table 155. Asia Pacific Orlistat Sales, by Application k Tons (2015-2020)
  • Table 156. Asia Pacific Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 157. Asia Pacific Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 158. China Orlistat Sales, by Type k Tons (2015-2020)
  • Table 159. China Orlistat Sales, by Application k Tons (2015-2020)
  • Table 160. China Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 161. China Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 162. Japan Orlistat Sales, by Type k Tons (2015-2020)
  • Table 163. Japan Orlistat Sales, by Application k Tons (2015-2020)
  • Table 164. Japan Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 165. Japan Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 166. India Orlistat Sales, by Type k Tons (2015-2020)
  • Table 167. India Orlistat Sales, by Application k Tons (2015-2020)
  • Table 168. India Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 169. India Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 170. South Korea Orlistat Sales, by Type k Tons (2015-2020)
  • Table 171. South Korea Orlistat Sales, by Application k Tons (2015-2020)
  • Table 172. South Korea Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 173. South Korea Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 174. Taiwan Orlistat Sales, by Type k Tons (2015-2020)
  • Table 175. Taiwan Orlistat Sales, by Application k Tons (2015-2020)
  • Table 176. Taiwan Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 177. Taiwan Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 178. Australia Orlistat Sales, by Type k Tons (2015-2020)
  • Table 179. Australia Orlistat Sales, by Application k Tons (2015-2020)
  • Table 180. Australia Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 181. Australia Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 182. Rest of Asia-Pacific Orlistat Sales, by Type k Tons (2015-2020)
  • Table 183. Rest of Asia-Pacific Orlistat Sales, by Application k Tons (2015-2020)
  • Table 184. Rest of Asia-Pacific Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 185. Rest of Asia-Pacific Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 186. Europe Orlistat Sales, by Country k Tons (2015-2020)
  • Table 187. Europe Orlistat Sales, by Type k Tons (2015-2020)
  • Table 188. Europe Orlistat Sales, by Application k Tons (2015-2020)
  • Table 189. Europe Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 190. Europe Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 191. Germany Orlistat Sales, by Type k Tons (2015-2020)
  • Table 192. Germany Orlistat Sales, by Application k Tons (2015-2020)
  • Table 193. Germany Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 194. Germany Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 195. France Orlistat Sales, by Type k Tons (2015-2020)
  • Table 196. France Orlistat Sales, by Application k Tons (2015-2020)
  • Table 197. France Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 198. France Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 199. Italy Orlistat Sales, by Type k Tons (2015-2020)
  • Table 200. Italy Orlistat Sales, by Application k Tons (2015-2020)
  • Table 201. Italy Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 202. Italy Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 203. United Kingdom Orlistat Sales, by Type k Tons (2015-2020)
  • Table 204. United Kingdom Orlistat Sales, by Application k Tons (2015-2020)
  • Table 205. United Kingdom Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 206. United Kingdom Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 207. Netherlands Orlistat Sales, by Type k Tons (2015-2020)
  • Table 208. Netherlands Orlistat Sales, by Application k Tons (2015-2020)
  • Table 209. Netherlands Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 210. Netherlands Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 211. Rest of Europe Orlistat Sales, by Type k Tons (2015-2020)
  • Table 212. Rest of Europe Orlistat Sales, by Application k Tons (2015-2020)
  • Table 213. Rest of Europe Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 214. Rest of Europe Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 215. MEA Orlistat Sales, by Country k Tons (2015-2020)
  • Table 216. MEA Orlistat Sales, by Type k Tons (2015-2020)
  • Table 217. MEA Orlistat Sales, by Application k Tons (2015-2020)
  • Table 218. MEA Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 219. MEA Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 220. Middle East Orlistat Sales, by Type k Tons (2015-2020)
  • Table 221. Middle East Orlistat Sales, by Application k Tons (2015-2020)
  • Table 222. Middle East Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 223. Middle East Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 224. Africa Orlistat Sales, by Type k Tons (2015-2020)
  • Table 225. Africa Orlistat Sales, by Application k Tons (2015-2020)
  • Table 226. Africa Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 227. Africa Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 228. North America Orlistat Sales, by Country k Tons (2015-2020)
  • Table 229. North America Orlistat Sales, by Type k Tons (2015-2020)
  • Table 230. North America Orlistat Sales, by Application k Tons (2015-2020)
  • Table 231. North America Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 232. North America Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 233. United States Orlistat Sales, by Type k Tons (2015-2020)
  • Table 234. United States Orlistat Sales, by Application k Tons (2015-2020)
  • Table 235. United States Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 236. United States Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 237. Canada Orlistat Sales, by Type k Tons (2015-2020)
  • Table 238. Canada Orlistat Sales, by Application k Tons (2015-2020)
  • Table 239. Canada Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 240. Canada Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 241. Mexico Orlistat Sales, by Type k Tons (2015-2020)
  • Table 242. Mexico Orlistat Sales, by Application k Tons (2015-2020)
  • Table 243. Mexico Orlistat Sales, by Distribution Channel k Tons (2015-2020)
  • Table 244. Mexico Orlistat Sales, by Prescription Mode k Tons (2015-2020)
  • Table 245. Orlistat: by Type(USD/Units)
  • Table 246. Company Basic Information, Sales Area and Its Competitors
  • Table 247. Company Basic Information, Sales Area and Its Competitors
  • Table 248. Company Basic Information, Sales Area and Its Competitors
  • Table 249. Company Basic Information, Sales Area and Its Competitors
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Orlistat: by Type(USD Million)
  • Table 257. Orlistat 120mg , by Region USD Million (2021-2026)
  • Table 258. Orlistat 60mg , by Region USD Million (2021-2026)
  • Table 259. Orlistat: by Application(USD Million)
  • Table 260. Orlistat Weight-reducing Aid , by Region USD Million (2021-2026)
  • Table 261. Orlistat Other , by Region USD Million (2021-2026)
  • Table 262. Orlistat: by Distribution Channel(USD Million)
  • Table 263. Orlistat Retailer , by Region USD Million (2021-2026)
  • Table 264. Orlistat Online , by Region USD Million (2021-2026)
  • Table 265. Orlistat Others , by Region USD Million (2021-2026)
  • Table 266. Orlistat: by Prescription Mode(USD Million)
  • Table 267. Orlistat Prescription Drugs , by Region USD Million (2021-2026)
  • Table 268. Orlistat OTC drugs , by Region USD Million (2021-2026)
  • Table 269. South America Orlistat, by Country USD Million (2021-2026)
  • Table 270. South America Orlistat, by Type USD Million (2021-2026)
  • Table 271. South America Orlistat, by Application USD Million (2021-2026)
  • Table 272. South America Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 273. South America Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 274. Brazil Orlistat, by Type USD Million (2021-2026)
  • Table 275. Brazil Orlistat, by Application USD Million (2021-2026)
  • Table 276. Brazil Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 277. Brazil Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 278. Argentina Orlistat, by Type USD Million (2021-2026)
  • Table 279. Argentina Orlistat, by Application USD Million (2021-2026)
  • Table 280. Argentina Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 281. Argentina Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 282. Rest of South America Orlistat, by Type USD Million (2021-2026)
  • Table 283. Rest of South America Orlistat, by Application USD Million (2021-2026)
  • Table 284. Rest of South America Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 285. Rest of South America Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 286. Asia Pacific Orlistat, by Country USD Million (2021-2026)
  • Table 287. Asia Pacific Orlistat, by Type USD Million (2021-2026)
  • Table 288. Asia Pacific Orlistat, by Application USD Million (2021-2026)
  • Table 289. Asia Pacific Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 290. Asia Pacific Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 291. China Orlistat, by Type USD Million (2021-2026)
  • Table 292. China Orlistat, by Application USD Million (2021-2026)
  • Table 293. China Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 294. China Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 295. Japan Orlistat, by Type USD Million (2021-2026)
  • Table 296. Japan Orlistat, by Application USD Million (2021-2026)
  • Table 297. Japan Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 298. Japan Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 299. India Orlistat, by Type USD Million (2021-2026)
  • Table 300. India Orlistat, by Application USD Million (2021-2026)
  • Table 301. India Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 302. India Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 303. South Korea Orlistat, by Type USD Million (2021-2026)
  • Table 304. South Korea Orlistat, by Application USD Million (2021-2026)
  • Table 305. South Korea Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 306. South Korea Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 307. Taiwan Orlistat, by Type USD Million (2021-2026)
  • Table 308. Taiwan Orlistat, by Application USD Million (2021-2026)
  • Table 309. Taiwan Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 310. Taiwan Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 311. Australia Orlistat, by Type USD Million (2021-2026)
  • Table 312. Australia Orlistat, by Application USD Million (2021-2026)
  • Table 313. Australia Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 314. Australia Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 315. Rest of Asia-Pacific Orlistat, by Type USD Million (2021-2026)
  • Table 316. Rest of Asia-Pacific Orlistat, by Application USD Million (2021-2026)
  • Table 317. Rest of Asia-Pacific Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 318. Rest of Asia-Pacific Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 319. Europe Orlistat, by Country USD Million (2021-2026)
  • Table 320. Europe Orlistat, by Type USD Million (2021-2026)
  • Table 321. Europe Orlistat, by Application USD Million (2021-2026)
  • Table 322. Europe Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 323. Europe Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 324. Germany Orlistat, by Type USD Million (2021-2026)
  • Table 325. Germany Orlistat, by Application USD Million (2021-2026)
  • Table 326. Germany Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 327. Germany Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 328. France Orlistat, by Type USD Million (2021-2026)
  • Table 329. France Orlistat, by Application USD Million (2021-2026)
  • Table 330. France Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 331. France Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 332. Italy Orlistat, by Type USD Million (2021-2026)
  • Table 333. Italy Orlistat, by Application USD Million (2021-2026)
  • Table 334. Italy Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 335. Italy Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 336. United Kingdom Orlistat, by Type USD Million (2021-2026)
  • Table 337. United Kingdom Orlistat, by Application USD Million (2021-2026)
  • Table 338. United Kingdom Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 339. United Kingdom Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 340. Netherlands Orlistat, by Type USD Million (2021-2026)
  • Table 341. Netherlands Orlistat, by Application USD Million (2021-2026)
  • Table 342. Netherlands Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 343. Netherlands Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 344. Rest of Europe Orlistat, by Type USD Million (2021-2026)
  • Table 345. Rest of Europe Orlistat, by Application USD Million (2021-2026)
  • Table 346. Rest of Europe Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 347. Rest of Europe Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 348. MEA Orlistat, by Country USD Million (2021-2026)
  • Table 349. MEA Orlistat, by Type USD Million (2021-2026)
  • Table 350. MEA Orlistat, by Application USD Million (2021-2026)
  • Table 351. MEA Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 352. MEA Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 353. Middle East Orlistat, by Type USD Million (2021-2026)
  • Table 354. Middle East Orlistat, by Application USD Million (2021-2026)
  • Table 355. Middle East Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 356. Middle East Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 357. Africa Orlistat, by Type USD Million (2021-2026)
  • Table 358. Africa Orlistat, by Application USD Million (2021-2026)
  • Table 359. Africa Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 360. Africa Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 361. North America Orlistat, by Country USD Million (2021-2026)
  • Table 362. North America Orlistat, by Type USD Million (2021-2026)
  • Table 363. North America Orlistat, by Application USD Million (2021-2026)
  • Table 364. North America Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 365. North America Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 366. United States Orlistat, by Type USD Million (2021-2026)
  • Table 367. United States Orlistat, by Application USD Million (2021-2026)
  • Table 368. United States Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 369. United States Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 370. Canada Orlistat, by Type USD Million (2021-2026)
  • Table 371. Canada Orlistat, by Application USD Million (2021-2026)
  • Table 372. Canada Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 373. Canada Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 374. Mexico Orlistat, by Type USD Million (2021-2026)
  • Table 375. Mexico Orlistat, by Application USD Million (2021-2026)
  • Table 376. Mexico Orlistat, by Distribution Channel USD Million (2021-2026)
  • Table 377. Mexico Orlistat, by Prescription Mode USD Million (2021-2026)
  • Table 378. Orlistat Sales: by Type(k Tons)
  • Table 379. Orlistat Sales 120mg , by Region k Tons (2021-2026)
  • Table 380. Orlistat Sales 60mg , by Region k Tons (2021-2026)
  • Table 381. Orlistat Sales: by Application(k Tons)
  • Table 382. Orlistat Sales Weight-reducing Aid , by Region k Tons (2021-2026)
  • Table 383. Orlistat Sales Other , by Region k Tons (2021-2026)
  • Table 384. Orlistat Sales: by Distribution Channel(k Tons)
  • Table 385. Orlistat Sales Retailer , by Region k Tons (2021-2026)
  • Table 386. Orlistat Sales Online , by Region k Tons (2021-2026)
  • Table 387. Orlistat Sales Others , by Region k Tons (2021-2026)
  • Table 388. Orlistat Sales: by Prescription Mode(k Tons)
  • Table 389. Orlistat Sales Prescription Drugs , by Region k Tons (2021-2026)
  • Table 390. Orlistat Sales OTC drugs , by Region k Tons (2021-2026)
  • Table 391. South America Orlistat Sales, by Country k Tons (2021-2026)
  • Table 392. South America Orlistat Sales, by Type k Tons (2021-2026)
  • Table 393. South America Orlistat Sales, by Application k Tons (2021-2026)
  • Table 394. South America Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 395. South America Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 396. Brazil Orlistat Sales, by Type k Tons (2021-2026)
  • Table 397. Brazil Orlistat Sales, by Application k Tons (2021-2026)
  • Table 398. Brazil Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 399. Brazil Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 400. Argentina Orlistat Sales, by Type k Tons (2021-2026)
  • Table 401. Argentina Orlistat Sales, by Application k Tons (2021-2026)
  • Table 402. Argentina Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 403. Argentina Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 404. Rest of South America Orlistat Sales, by Type k Tons (2021-2026)
  • Table 405. Rest of South America Orlistat Sales, by Application k Tons (2021-2026)
  • Table 406. Rest of South America Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 407. Rest of South America Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 408. Asia Pacific Orlistat Sales, by Country k Tons (2021-2026)
  • Table 409. Asia Pacific Orlistat Sales, by Type k Tons (2021-2026)
  • Table 410. Asia Pacific Orlistat Sales, by Application k Tons (2021-2026)
  • Table 411. Asia Pacific Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 412. Asia Pacific Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 413. China Orlistat Sales, by Type k Tons (2021-2026)
  • Table 414. China Orlistat Sales, by Application k Tons (2021-2026)
  • Table 415. China Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 416. China Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 417. Japan Orlistat Sales, by Type k Tons (2021-2026)
  • Table 418. Japan Orlistat Sales, by Application k Tons (2021-2026)
  • Table 419. Japan Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 420. Japan Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 421. India Orlistat Sales, by Type k Tons (2021-2026)
  • Table 422. India Orlistat Sales, by Application k Tons (2021-2026)
  • Table 423. India Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 424. India Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 425. South Korea Orlistat Sales, by Type k Tons (2021-2026)
  • Table 426. South Korea Orlistat Sales, by Application k Tons (2021-2026)
  • Table 427. South Korea Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 428. South Korea Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 429. Taiwan Orlistat Sales, by Type k Tons (2021-2026)
  • Table 430. Taiwan Orlistat Sales, by Application k Tons (2021-2026)
  • Table 431. Taiwan Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 432. Taiwan Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 433. Australia Orlistat Sales, by Type k Tons (2021-2026)
  • Table 434. Australia Orlistat Sales, by Application k Tons (2021-2026)
  • Table 435. Australia Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 436. Australia Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 437. Rest of Asia-Pacific Orlistat Sales, by Type k Tons (2021-2026)
  • Table 438. Rest of Asia-Pacific Orlistat Sales, by Application k Tons (2021-2026)
  • Table 439. Rest of Asia-Pacific Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 440. Rest of Asia-Pacific Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 441. Europe Orlistat Sales, by Country k Tons (2021-2026)
  • Table 442. Europe Orlistat Sales, by Type k Tons (2021-2026)
  • Table 443. Europe Orlistat Sales, by Application k Tons (2021-2026)
  • Table 444. Europe Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 445. Europe Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 446. Germany Orlistat Sales, by Type k Tons (2021-2026)
  • Table 447. Germany Orlistat Sales, by Application k Tons (2021-2026)
  • Table 448. Germany Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 449. Germany Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 450. France Orlistat Sales, by Type k Tons (2021-2026)
  • Table 451. France Orlistat Sales, by Application k Tons (2021-2026)
  • Table 452. France Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 453. France Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 454. Italy Orlistat Sales, by Type k Tons (2021-2026)
  • Table 455. Italy Orlistat Sales, by Application k Tons (2021-2026)
  • Table 456. Italy Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 457. Italy Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 458. United Kingdom Orlistat Sales, by Type k Tons (2021-2026)
  • Table 459. United Kingdom Orlistat Sales, by Application k Tons (2021-2026)
  • Table 460. United Kingdom Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 461. United Kingdom Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 462. Netherlands Orlistat Sales, by Type k Tons (2021-2026)
  • Table 463. Netherlands Orlistat Sales, by Application k Tons (2021-2026)
  • Table 464. Netherlands Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 465. Netherlands Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 466. Rest of Europe Orlistat Sales, by Type k Tons (2021-2026)
  • Table 467. Rest of Europe Orlistat Sales, by Application k Tons (2021-2026)
  • Table 468. Rest of Europe Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 469. Rest of Europe Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 470. MEA Orlistat Sales, by Country k Tons (2021-2026)
  • Table 471. MEA Orlistat Sales, by Type k Tons (2021-2026)
  • Table 472. MEA Orlistat Sales, by Application k Tons (2021-2026)
  • Table 473. MEA Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 474. MEA Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 475. Middle East Orlistat Sales, by Type k Tons (2021-2026)
  • Table 476. Middle East Orlistat Sales, by Application k Tons (2021-2026)
  • Table 477. Middle East Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 478. Middle East Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 479. Africa Orlistat Sales, by Type k Tons (2021-2026)
  • Table 480. Africa Orlistat Sales, by Application k Tons (2021-2026)
  • Table 481. Africa Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 482. Africa Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 483. North America Orlistat Sales, by Country k Tons (2021-2026)
  • Table 484. North America Orlistat Sales, by Type k Tons (2021-2026)
  • Table 485. North America Orlistat Sales, by Application k Tons (2021-2026)
  • Table 486. North America Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 487. North America Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 488. United States Orlistat Sales, by Type k Tons (2021-2026)
  • Table 489. United States Orlistat Sales, by Application k Tons (2021-2026)
  • Table 490. United States Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 491. United States Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 492. Canada Orlistat Sales, by Type k Tons (2021-2026)
  • Table 493. Canada Orlistat Sales, by Application k Tons (2021-2026)
  • Table 494. Canada Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 495. Canada Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 496. Mexico Orlistat Sales, by Type k Tons (2021-2026)
  • Table 497. Mexico Orlistat Sales, by Application k Tons (2021-2026)
  • Table 498. Mexico Orlistat Sales, by Distribution Channel k Tons (2021-2026)
  • Table 499. Mexico Orlistat Sales, by Prescription Mode k Tons (2021-2026)
  • Table 500. Orlistat: by Type(USD/Units)
  • Table 501. Research Programs/Design for This Report
  • Table 502. Key Data Information from Secondary Sources
  • Table 503. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Orlistat: by Type USD Million (2015-2020)
  • Figure 5. Global Orlistat: by Application USD Million (2015-2020)
  • Figure 6. Global Orlistat: by Distribution Channel USD Million (2015-2020)
  • Figure 7. Global Orlistat: by Prescription Mode USD Million (2015-2020)
  • Figure 8. South America Orlistat Share (%), by Country
  • Figure 9. Asia Pacific Orlistat Share (%), by Country
  • Figure 10. Europe Orlistat Share (%), by Country
  • Figure 11. MEA Orlistat Share (%), by Country
  • Figure 12. North America Orlistat Share (%), by Country
  • Figure 13. Global Orlistat: by Type k Tons (2015-2020)
  • Figure 14. Global Orlistat: by Application k Tons (2015-2020)
  • Figure 15. Global Orlistat: by Distribution Channel k Tons (2015-2020)
  • Figure 16. Global Orlistat: by Prescription Mode k Tons (2015-2020)
  • Figure 17. South America Orlistat Share (%), by Country
  • Figure 18. Asia Pacific Orlistat Share (%), by Country
  • Figure 19. Europe Orlistat Share (%), by Country
  • Figure 20. MEA Orlistat Share (%), by Country
  • Figure 21. North America Orlistat Share (%), by Country
  • Figure 22. Global Orlistat: by Type USD/Units (2015-2020)
  • Figure 23. Global Orlistat share by Players 2020 (%)
  • Figure 24. Global Orlistat share by Players (Top 3) 2020(%)
  • Figure 25. Global Orlistat share by Players (Top 5) 2020(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. F. Hoffmann-La Roche AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 28. F. Hoffmann-La Roche AG (Switzerland) Revenue: by Geography 2020
  • Figure 29. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2020
  • Figure 31. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 32. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2020
  • Figure 33. Sandoz International GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Sandoz International GmbH (Germany) Revenue: by Geography 2020
  • Figure 35. STADA-VN J.V.Co., Ltd (Vietnam) Revenue, Net Income and Gross profit
  • Figure 36. STADA-VN J.V.Co., Ltd (Vietnam) Revenue: by Geography 2020
  • Figure 37. Hexal AG (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Hexal AG (Germany) Revenue: by Geography 2020
  • Figure 39. National Company for Pharmaceutical Industry (Oman) Revenue, Net Income and Gross profit
  • Figure 40. National Company for Pharmaceutical Industry (Oman) Revenue: by Geography 2020
  • Figure 41. Lunan Pharmaceutical Group Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 42. Lunan Pharmaceutical Group Co., Ltd. (China) Revenue: by Geography 2020
  • Figure 43. ZEIN pharmaceutical (China) Revenue, Net Income and Gross profit
  • Figure 44. ZEIN pharmaceutical (China) Revenue: by Geography 2020
  • Figure 45. Zhejiang Hisun Pharmaceutical Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 46. Zhejiang Hisun Pharmaceutical Co., Ltd. (China) Revenue: by Geography 2020
  • Figure 47. Global Orlistat: by Type USD Million (2021-2026)
  • Figure 48. Global Orlistat: by Application USD Million (2021-2026)
  • Figure 49. Global Orlistat: by Distribution Channel USD Million (2021-2026)
  • Figure 50. Global Orlistat: by Prescription Mode USD Million (2021-2026)
  • Figure 51. South America Orlistat Share (%), by Country
  • Figure 52. Asia Pacific Orlistat Share (%), by Country
  • Figure 53. Europe Orlistat Share (%), by Country
  • Figure 54. MEA Orlistat Share (%), by Country
  • Figure 55. North America Orlistat Share (%), by Country
  • Figure 56. Global Orlistat: by Type k Tons (2021-2026)
  • Figure 57. Global Orlistat: by Application k Tons (2021-2026)
  • Figure 58. Global Orlistat: by Distribution Channel k Tons (2021-2026)
  • Figure 59. Global Orlistat: by Prescription Mode k Tons (2021-2026)
  • Figure 60. South America Orlistat Share (%), by Country
  • Figure 61. Asia Pacific Orlistat Share (%), by Country
  • Figure 62. Europe Orlistat Share (%), by Country
  • Figure 63. MEA Orlistat Share (%), by Country
  • Figure 64. North America Orlistat Share (%), by Country
  • Figure 65. Global Orlistat: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • F. Hoffmann-La Roche AG (Switzerland)
  • GlaxoSmithKline plc (United Kingdom)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sandoz International GmbH (Germany)
  • STADA-VN J.V.Co., Ltd (Vietnam)
  • Hexal AG (Germany)
  • National Company for Pharmaceutical Industry (Oman)
  • Lunan Pharmaceutical Group Co., Ltd. (China)
  • ZEIN pharmaceutical (China)
  • Zhejiang Hisun Pharmaceutical Co., Ltd. (China)
Additional players considered in the study are as follows:
Taj Pharmaceuticals Ltd (India) , Kabir Life Sciences & Research (India) , DM Pharma (India) , Zhongshan Pharm (China)
Select User Access Type

Key Highlights of Report


Aug 2021 227 Pages 54 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Orlistat Quantitative research analysis
Global Orlistat Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Orlistat market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Orlistat market are F. Hoffmann-La Roche AG (Switzerland), GlaxoSmithKline plc (United Kingdom), Teva Pharmaceutical Industries Ltd. (Israel), Sandoz International GmbH (Germany), STADA-VN J.V.Co., Ltd (Vietnam), Hexal AG (Germany), National Company for Pharmaceutical Industry (Oman), Lunan Pharmaceutical Group Co., Ltd. (China), ZEIN pharmaceutical (China) and Zhejiang Hisun Pharmaceutical Co., Ltd. (China), to name a few.
North America is dominating the Orlistat Market.

Know More About Global Orlistat Report?

Have a Query? Click Here

Other Related Reports

Iron Chelation Drug Comprehensive Study by Type (Deferoxamine, Deferiprone, Deferasirox), Application (Transfusional Iron Overload, NTDT Caused Iron Overload), Distribution Channel (Online, Offline) ...
$ 3500
Saffron Tablets Comprehensive Study by Type (Sugar Coated Tablet, Film Coated Tablet, Other), Application (Pharmaceutical, Nutraceutical), End User (Hospital Pharmacy, Retail Pharmacies, Online Pharm...
$ 3500
Probiotic Powder Comprehensive Study by Type (Bifidobacterium, Lactobacillus, Saccharomyces Boulardii, Streptococcus Thermophilus, Others), Application (Food & Beverage, Drugs, Dietary Supplements, O...
$ 3650
Empty Capsules Comprehensive Study by Type (Gelatin Capsule, Non-gelatin Capsule), Application (Antibiotic & Antibacterial Drug, Vitamin & Dietary Supplement, Antacids & Anti-flatulent Preparation, C...
$ 3750
Almagate Comprehensive Study by Type (Suspension Agent, Chewable Tablets), Application (Baby, Adult), Sales Channel (Online, Offline) Players and Region - South Korea Market Outlook to 2025
$ 3500
Halal Pharmaceuticals Comprehensive Study by Type (Tablets, Syrups, Capsules), Application (Health Care Products, Drugs), Dosage Forms (Prescription, Non-prescription), Drug Class (Respiratory drugs,...
$ 3750